VERU INC. SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery
VERU INC. (VERU) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery of -$31.63 thousand for the 12-month period ending 2013-09-30, per its 10-K filed 2013-12-03.
Discontinued › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesRecoveries · last filed 2013-12-03
- VERU INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2013 was -$31.63K.
- VERU INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2012 was -$10.75K.
- VERU INC. sec schedule, 12-09, valuation allowances and reserves, addition, recovery for fiscal 2011 was -$35.84K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery 12 month |
|---|---|
| 2013-09-30 | -$31.63K 10-K · filed 2013-12-03 |
| 2012-09-30 | -$10.75K 10-K · filed 2013-12-03 |
| 2011-09-30 | -$35.84K 10-K · filed 2013-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |